| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.24 | 6e-12 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.28 | 2e-08 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.18 | 7e-05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0005 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0006 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |